Replication-competent adenoviral vectors which selectively replicate in cancer cells are provided. The replication-competent viral vectors comprise an E2F responsive promoter and/or a telomerase promoter operatively linked to an adenoviral coding region. The replication-competent adenoviral vectors effectively replicate in a variety of types of cancer cells and find broad utility in the treatment of cancer.

 
Web www.patentalert.com

< COMPOSITIONS AND METHODS FOR REGULATED PROTEIN EXPRESSION IN GUT

> Internalisation of virus into cells

~ 00489